Early outcomes from the CLASP IID trial roll‐in cohort for prohibitive risk patients with degenerative mitral regurgitation
Lim D, Smith R, Zahr F, Dhoble A, Laham R, Lazkani M, Kodali S, Kliger C, Hermiller J, Vora A, Sarembock I, Gray W, Kapadia S, Greenbaum A, Rassi A, Lee D, Chhatriwalla A, Shah P, Rodés‐Cabau J, Ibrahim H, Satler L, Herrmann H, Mahoney P, Davidson C, Petrossian G, Guerrero M, Koulogiannis K, Marcoff L, Gillam L, Investigators T. Early outcomes from the CLASP IID trial roll‐in cohort for prohibitive risk patients with degenerative mitral regurgitation. Catheterization And Cardiovascular Interventions 2021, 98: e637-e646. PMID: 34004077, DOI: 10.1002/ccd.29749.Peer-Reviewed Original ResearchConceptsRoll-in cohortRoll-in patientsRe-interventionMyocardial infarctionSurgical riskSevere bleedingPASCAL transcatheter valve repair systemMitral valve re-interventionCentral screening committeeClinically significant MREchocardiographic core laboratoryNYHA class I/IIPASCAL repair systemValve re-interventionDegenerative mitral regurgitationNYHA class III/IVClinical events committeeLocal heart teamRenal replacement therapyClass III/IVMitral regurgitationPivotal trialsRisk patientsSignificant MRTranscatheter repair
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply